Frieman

Behavioral Health’s Forge Health Marks Next Phase with Board of Directors Expansion and Advisory Board Creation

Retrieved on: 
Thursday, March 28, 2024
General Health, Health, Mental Health, Diagnosis, Anthem, Innovation, Advisory board, BCBS, Entrepreneurship, EVP, Patient, Mental health, SVP, Forge, Digital health, Cigna, Paul McBride, MD, Yale School of Medicine, Senior, JD, Medicine, Frieman, Management

Mental health and substance use care continue to be far from affordable or accessible for millions of people in need.

Key Points: 
  • Mental health and substance use care continue to be far from affordable or accessible for millions of people in need.
  • However, the gap takes a notable step toward closing today as Forge Health announces a significant board and advisory expansion.
  • The New York-based provider of hybrid treatment options, serving thousands of patients, has added three new members to its board of directors, including a new board observer, and announced the formation of an Advisory Board.
  • The Forge care model utilizes multidisciplinary clinical teams, data analytics, and streamlined care delivery to provide individualized, whole-person care that concurrently addresses mental health and substance use issues while driving improved health outcomes.

Cole-Frieman & Mallon Promotes Three as Investment Management Law Firm Sees Growth

Retrieved on: 
Friday, June 4, 2021
Alternative investment management companies, Institutional investors, Hedge fund, Frieman

We handled over 150 fund launches last year, and this year we expect even more growth," said Karl Cole-Frieman.

Key Points: 
  • We handled over 150 fund launches last year, and this year we expect even more growth," said Karl Cole-Frieman.
  • The firm has continued to expand into new areas of both the traditional and digital asset management spaces.
  • About Cole-Frieman & Mallon: Cole-Frieman & Mallon LLP is one of the top investment management law firms in the United States, known for providing top-tier, innovative, and collaborative legal solutions for complex financial services matters.
  • The Firm also publishes the prominent Hedge Fund Law Blog, which focuses on legal issues that impact the hedge fund community.

AIkido Pharma Announces Inventor and Scientist Dr. Matthew Frieman Joins Scientific Advisory Board

Retrieved on: 
Monday, April 26, 2021
Japanese martial arts, Frieman, Aiki

b'NEW YORK, April 26, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matthew Frieman has joined the Company\'s Scientific Advisory Board.\n"Dr. Frieman is a world-class scientist and inventor.

Key Points: 
  • b'NEW YORK, April 26, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matthew Frieman has joined the Company\'s Scientific Advisory Board.\n"Dr. Frieman is a world-class scientist and inventor.
  • His research is truly cutting edge and his work is advancing the science in this tremendously important field," commented Mr. Anthony Hayes, CEO of AIkido.
  • The coronavirus is still a notable issue that continues to impact society and we are very proud to be supporting Dr. Frieman\'s work."\nDr.
  • His work on coronavirus replication derives from his interest in studying how the virus interacts with the cellular machinery during infection.

AIkido Pharma Announces Dr. Matt Frieman's Appearance on This Week in Virology

Retrieved on: 
Friday, March 12, 2021
Japanese martial arts, This Week in Virology, Frieman, Aiki

NEW YORK, March 12, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matt Frieman appeared on the video podcast This Week in Virology, segment entitled " TWiV 729: A floret of spikes with Matt Frieman ."

Key Points: 
  • NEW YORK, March 12, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matt Frieman appeared on the video podcast This Week in Virology, segment entitled " TWiV 729: A floret of spikes with Matt Frieman ."
  • The entire video can be seen here: https://www.microbe.tv/twiv/
    At the forty-two minute mark, Dr. Frieman discusses the future of this type of virology work and his work on the pan-viral initiative with AIkido Pharma.
  • The Company is proud to be working with industry leaders like Dr. Frieman in the development of a family of pan-viral drugs.
  • AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics.

Cole-Frieman & Mallon LLP Announces New Partner Scott E. Kitchens

Retrieved on: 
Tuesday, May 21, 2019
Law firm, Practice of law, Frieman

SAN FRANCISCO, May 21, 2019 /PRNewswire-PRWeb/ --Cole-Frieman & Mallon LLP, a leading boutique investment management law firm, is pleased to announce Scott Kitchens has joined the firm as a partner.

Key Points: 
  • SAN FRANCISCO, May 21, 2019 /PRNewswire-PRWeb/ --Cole-Frieman & Mallon LLP, a leading boutique investment management law firm, is pleased to announce Scott Kitchens has joined the firm as a partner.
  • Mr. Kitchens previously worked in the investment management practice group of a large international law firm.
  • "I am very excited to join Cole-Frieman & Mallon and launch its Denver office," said Mr. Kitchens.
  • Cole-Frieman & Mallon LLP is a premier boutique investment management law firm, providing top-tier, responsive and cost-effective legal solutions for financial services matters.